RBC Capital Markets reiterated its Outperform rating on one well-known MedTech stock in a note this week, calling it a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE